A Study to Assess Anktiva in Patients With Long Covid-19.

NCT07108036 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Long COVID

Interventions

DRUG: N-803 (IL-15 Superagonist)

Sponsor

ImmunityBio, Inc.